Abstract In August 2013, the National Institutes of Health sponsored a conference to address
major gaps in our understanding of the epidemiology, pathophysiology, and management of …

Background Over the past 18 years neuromodulation therapies have gained support as
treatments for faecal incontinence (FI); sacral nerve stimulation (SNS) is the most …

Background: Sacral nerve stimulation has been approved for use in treating urinary
incontinence in the United States since 1997, and in Europe for both urinary and fecal …

Purpose: This randomized study was designed to compare the effect of sacral
neuromodulation with optimal medical therapy in patients with severe fecal incontinence …

Background Sacral nerve stimulation (SNS) has proven short-to medium-term effectiveness
for the treatment of faecal incontinence (FI); fewer long-term outcomes have been presented …

BACKGROUND AND OBJECTIVE: Sacral nerve stimulation is effective in the treatment of
urinary incontinence and is currently under Food and Drug Administration review in the …

Abstract Aim In Europe during the last decade sacral nerve stimulation (SNS) or sacral
neuromodulation (SNM) has been used to treat faecal incontinence (FI) and constipation …

BACKGROUND: Despite its prevalence and deleterious impact on patients and families,
fecal incontinence remains an understudied condition. Few data are available on its …

Purpose: This prospective study was designed to assess the effectiveness of sacral nerve
stimulation for fecal incontinence in patients with external anal sphincter defect and to …

Aim The efficacy of sacral nerve stimulation (SNS) to treat faecal incontinence has been
demonstrated in the short‐and mid‐term. We analysed SNS outcome in the first patients with …